Uncategorized - October 18, 2022
New RDI environment launched in Helsinki
The grand opening of Health Proof Helsinki was held on 5 October 2022 at the Myllypuro campus of Metropolia University of Applied Sciences in Helsinki. Health Proof Helsinki is a a new health sector test environment ecosystem for research, development and innovation (RDI) providing companies with a service chain from early product development towards clinical […]
Collaboration - September 21, 2022
RWE on the agenda at US-Swedish event
During a meeting at the US ambassador’s residence in Sweden on September 20th, collaboration on data driven life sciences and Real World Evidence’s (RWE’s) impact on Swedish life sciences was discussed. The meeting was arranged by MSD, SwedenBIO, Karolinska Institutet and the American Chamber of Commerce. “The event was important in order to showcase concrete […]
Collaboration - September 13, 2022
Novo Nordisk and Microsoft enter collaboration
The two companies have entered a new strategic collaboration to combine Microsoft’s computational services, cloud and artificial intelligence with Novo Nordisk’s drug discovery, development and data science capabilities. Through the partnership, Microsoft is providing AI technology, foundational science models and expertise and is working alongside Novo Nordisk’s data scientists and domain experts from early research […]
Acquisition - August 19, 2022
iZafe to acquire Pilloxa
iZafe Group has signed a letter of intent with Pilloxa regarding the acquisition of 100 per cent of the shares in Pilloxa. Pilloxa has developed a technology platform for better compliance that pharmaceutical companies use to design digital patient support. The acquisition creates a new company in digital health that is well positioned to become […]
Collaboration - June 22, 2022
Zealand Pharma collaborates with Iktos
Under the agreement, Zealand will contribute its expertise in peptide drug discovery to Iktos’ generative modelling technologies and expertise in machine learning and AI. “We are very pleased to join forces with Zealand Pharma and leverage their deep know-how in peptide therapeutics with our state-of-the-art existing technology assets to peptide drug discovery,” says Yann Gaston-Mathé, […]
Collaboration - May 16, 2022
BC Platforms announces partnerships with three Finnish biobanks
BC Platforms has secured a multi-year contract to work with three Finnish Hospital District owned Biobanks (Clinical Biobanks) on improving access to, and automated management of, phenotypic, genomic, and clinical data. The project underpins Finland’s ambition to be a leading country for Real-World Data (RWD) studies, supporting the global development of novel treatments and enhancing […]
